News

Eurofins Viracor has launched the BKV inSIGHT™ T-Cell Immunity Panel (TCIP), a new assay that measures BK virus-specific T-cell immunity in kidney transplant patients with recent-onset BK viremia. The test provides clinicians with insight into a patient's ability to control BK virus replication, helping inform immunosuppression management and support comprehensive transplant patient monitoring.

Eurofins Viracor has launched three new plasma-based immune monitoring assays, CXCL9, CXCL10, and IL-18, for transplant and immunocompromised patients. These biomarkers provide insight into immune activation and inflammation using a minimally invasive blood sample. The tests are available with a 24-hour turnaround time and further expand Eurofins Viracor's transplant and immunology testing portfolio.

Eurofins Viracor has launched the ExPeCT™ anti-CD19 (obe-cel) CAR T-cell assay, a new diagnostic solution designed to support proactive monitoring of next-generation CAR T-cell therapies. This non-invasive blood test enables real-time assessment of CAR T-cell expansion and persistence, delivering results in approximately 24 hours after specimen receipt. Developed specifically for testing obecabtagene autoleucel (obe-cel), the assay helps clinicians gain timely, validated insights to support informed therapy decisions.

Eurofins Viracor has launched multiplex pneumococcal antibody assays covering all vaccine serotypes, including PCV21. The 32‑serotype panel improves accuracy and supports personalized immunity monitoring. This advancement reinforces the company’s leadership in immunology diagnostics.

We're pleased to announce the launch of our new quantitative real-time PCR assays for the rapid detection of clinically significant dimorphic fungi, including Blastomyces, Histoplasma, Coccidioides, and Cryptococcus species...

At Eurofins Viracor, we’re advancing respiratory infection diagnostics with the introduction of a bronchoalveolar lavage (BAL) specimen type for our NeXGen® Fungal / Acid Fast Bacteria (AFB) NGS assay...

Eurofins Viracor has launched a quantitative PCR assay for the detection of Trypanosoma cruzi (T. cruzi), the parasite responsible for Chagas disease...

Eurofins Scientific (EUFI.PA), a global leader in bioanalytical testing, announces the closing of its acquisition of Ascend Clinical, LLC (“Ascend”), the largest independent laboratory for...

With Illumina Connected Analytics, Eurofins Viracor can now analyze complex data sets, freeing them up to make greater discoveries Around the world, sequencing laboratories are experiencing an increase in the demand for clinical next-generation sequencing (NGS). But with that demand comes the possibility of a bioinformatics bottleneck. No one understands this more than Eurofins ...

Eurofins Viracor ExPeCT™ CAR-T multiplexed quantitative real-time PCR (qPCR) assay provides a powerful diagnostic tool to monitor and optimize CAR-T therapy...